Generalizability Of Prophylactic ICD Benefits Questioned By CMS, Panelists

CMS' reliance on the precise wording of Guidant's original national coverage determination request for expanded ICD use suggests the need for companies to tailor their requests to avoid overly broad interpretations

More from Archive

More from Medtech Insight